Section 1 - National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 49 of 2006) - National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 49 of 2006)

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUBSECTION 85(2AA)

No. PB 49 OF 2006

I, JOAN CORBETT, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, having in accordance with subsection 85(2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85(2AA) of the National Health Act 1953 hereby make the following Declaration:

This Declaration commences on 1 December 2006.
The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

Benzyl Benzoate

Oestradiol Valerate and Oestradiol Valerate with Cyproterone Acetate

“PK Max”

Quinidine Bisulfate

Dated this 7th day of November 2006.

JOAN CORBETT

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Delegate of the Minister for Health and Ageing

1National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 49 of 2006)

Get a plain-English read of 1